Non-carbapenem therapy of urinary tract infections caused by extended-spectrum β-lactamase-producing Enterobacteriaceae.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

We determined the prevalence of ESBL Enterobacteriaceae in urinary tract infections among inpatients, identified risk factors of acquisition, and evaluated the effectiveness of alternatives to carbapenems.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Med Mal Infect

Title: Medecine et maladies infectieuses

Publisher: Elsevier BV

ISSN (Electronic): 1769-6690

ISSN (Print): 0399-077X

Publication date (Electronic): May 2015

Volume: 45

Issue: 5

Affiliations

[1 ] Service des maladies infectieuses, CHU de Caen, avenue de la Côte-de-Nacre, 14033 Caen cedex 9, France. Electronic address: delablanchardiere-a@chu-caen.fr.

[2 ] Service des maladies infectieuses, CHU de Caen, avenue de la Côte-de-Nacre, 14033 Caen cedex 9, France.

[3 ] Service de microbiologie, CHU de Caen, Caen, France.

[4 ] Service de pharmacie, CHU de Caen, Caen, France.

Article

Publisher Item ID: S0399-077X(15)00064-5

DOI: 10.1016/j.medmal.2015.03.003

PubMed ID: 25845927

SO-VID: 87815782-ac50-451f-bb4e-ee1860b1c6a9

History

Keywords: ESBL Enterobacteriaceae,Urinary tract infection,Pipéracilline-tazobactam,Piperacillin-tazobactam,Infection urinaire,Entérobactéries BLSE

Data availability:

Keywords: ESBL Enterobacteriaceae, Urinary tract infection, Pipéracilline-tazobactam, Piperacillin-tazobactam, Infection urinaire, Entérobactéries BLSE

Non-carbapenem therapy of urinary tract infections caused by extended-spectrum β-lactamase-producing Enterobacteriaceae.

Read this article at

Abstract

Related collections

Negative Pressure Wound Therapy

Author and article information

Journal

Affiliations

Article

History

Comments

Comment on this article

Cited by 6